Spanish Version of the Balance Evaluation Systems Test and Mini Balance Evaluation Systems Test (BESTest)

January 17, 2018 updated by: Pilar Dominguez-Olivan, Universidad de Zaragoza

Translation and Validation of the Spanish Version of the BESTest and Mini-BESTest

This study aim to translate the BESTest and mini-BESTest to Spanish, adapt it and investigate its validity in spanish population.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

To translate the BESTest and mini-BESTest to Spanish, adapt it and investigate its validity in spanish. Check its metric properties in relation to other balance tests.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Zaragoza, Spain, 50009
        • Facultad de Ciencias de la Salud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 85 years (OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria: healthy subjects without diagnosed balance problems.

-

Exclusion Criteria:

  • Diagnosed balance problems.
  • One falling in the last three months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: case group
BESTest, mini-BESTest, Berg scale and FES (falls efficacy scale) (in Spanish version is administrated in case group.
Behavioral: Case group
assessment of quality on posture, transfers and displacement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Concurrent validity of Best test- 1
Time Frame: 1 month
concurrent validity of BESTest compare to other model balance tests
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychometric properties of Spanish version of BESTest.
Time Frame: 1 year
To perform a detailed analysis of the psychometric properties of the BESTest Spanish version.
1 year
Psychometric properties of Spanish version of mini-BESTest.
Time Frame: 1 year
To perform a detailed analysis of the psychometric properties of the mini-BESTest Spanish version.
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
concurrent validity of mini-BESTest
Time Frame: 1 month
concurrent validity of mini-BESTest compare to Berg scale and FES.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad de Zaragoza

Collaborators

Instituto Aragones de Ciencias de la Salud

Investigators

  • Study Chair: Angel Mr Lanas-Arbeloa, Instituto de Investigacion Sanitaria de Aragon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 18, 2017

Primary Completion (Actual)

November 16, 2017

Study Completion (Actual)

December 30, 2017

Study Registration Dates

First Submitted

September 23, 2017

First Submitted That Met QC Criteria

January 17, 2018

First Posted (Actual)

January 18, 2018

Study Record Updates

Last Update Posted (Actual)

January 18, 2018

Last Update Submitted That Met QC Criteria

January 17, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • PI17/0282

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Blind date analysis researcher. By coding affiliation information.

IPD Sharing Time Frame

data will become available from October 2017 and for three months.

IPD Sharing Access Criteria

affiliation date are code. The rest of registration is shared.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Balance

Clinical Trials on Case group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe